Method of enhancing miR-185 expression to reduce low density  lipoprotein/cholesterol accumulation in a cell
The present invention provides a method of quantifying miR-185 as a potential biomarker in lipid disorder or cardiovascular diseases in human. The present invention also provides a method of modulating miR-185 in regulating LDL and cholesterol metabolism in cells. The present invention has therapeutic potential in the treatment of cholesterol/LDL related cardiovascular diseases in humans.
Medical Diagnostic Laboratories, LLC
C C C C C C C C C
C12N C12N C12Q C12N C12Y C12N C12Q C12Q C12Y
inventional additional inventional inventional additional inventional additional additional additional
Muhua Weidong Christina Ann Joseph T
Yang Liu Pellicane Nickels, Jr.